揭示自闭症谱系障碍的有希望的药物标:从遗传学,转录组学和蛋白质组学的见解
Rui Jiang1,2,3, Wentao Huang1,2, Xinqi Qiu4
1Department of Gastroenterology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No. 106, Zhongshan 2nd Road, Guangzhou 510080, China.
Briefings in bioinformatics
|July 22, 2024
概括
这项研究通过分析遗传数据和药物相互作用,确定了自闭症谱系障碍 (ASD) 的17个潜在治疗点. 这些发现为开发有针对性的ASD疗法和重新利用现有的药物提供了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 自闭症谱系障碍 (ASD) 是一种复杂的神经发育状况,治疗选择有限.
- 开发针对ASD的向疗法受到高药开发成本和缺乏确定的药物标的阻碍.
研究的目的:
- 通过使用综合遗传和蛋白质组数据,识别和验证自闭症谱系障碍 (ASD) 的潜在治疗点.
- 通过途径和药物丰富分析,探索潜在的生物机制并评估已识别的点的治疗潜力.
主要方法:
- 利用GTEx (表达量性特征位点) 和ROSMAP (蛋白质量性特征位点) 的总结级数据,以及ASD全基因组关联研究.
- 采用孟德尔随机化 (MR),全转录组关联研究,贝叶斯定位化和基于总结数据的MR用于目标发现和复制.
- 进行了途径分析,药物丰富,蛋白与蛋白相互作用 (PPI) 网络分析,并使用了小鼠淘汰模式.
主要成果:
- 确定了17个与ASD因果相关的基因作为潜在的治疗点.
- 在全蛋白质组MR分析中,复制的Cathepsin B (CTSB),胺黄油酸B型受体子单元1 (GABBR1) 和formin like 1 (FMNL1).
- 推断阿卡姆酸盐 (GABBR1抑制剂) 和布里奥斯1 (CASP8抑制剂) 作为ASD的潜在治疗剂;小鼠模型支持CASP8,GABBR1和PLEKHM1.1的作用.
结论:
- 这项研究提出了17个新的ASD候选治疗点,推动了向治疗的发展.
- 这些发现突出了药物重新使用的机会,并为未来在ASD中进行药理干预提供了基础.
相关概念视频
Autism Spectrum Disorder
79
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
79
Human Genetics
552
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
552
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
552
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
552
Biological Causes of Schizophrenia
51
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
51


